^
    An in vitro diagnostic medical device for quantitatively analyzing the presence or absence of PIK3CA mutation and prescribing the target drug Alpelisib using DNA extracted from FFPE and plasma of HR+, HER2- breast cancer patients
    Cancer:
    Breast Cancer, Non Small Cell Lung Cancer
    Gene:
    PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha)
    Drug:
    Piqray (alpelisib)
    Method:
    PCR
    Approvals
    Date
    Cancer
    Gene
    Drug
    By
    04/21/22
    BC
    PIK3CA
    CE